| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/21/2005 | US20050158726 Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/21/2005 | US20050158725 Method of amplifying nucleic acid by electromagnetic induction heating and reaction container and reaction device to be used therein |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158722 Nucleic acid quantification |
| 07/21/2005 | US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure |
| 07/21/2005 | US20050158720 Tripartite molecular beacons |
| 07/21/2005 | US20050158719 Polypeptide serving as angiogenic marker and dna thereof |
| 07/21/2005 | US20050158718 Diagnostic and therapeutic uses of SUFU gene |
| 07/21/2005 | US20050158716 Nucleic acid detection kits |
| 07/21/2005 | US20050158715 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158713 Fitness assay and associated methods |
| 07/21/2005 | US20050158712 Methods for purifying viral particles for gene therapy |
| 07/21/2005 | US20050158711 viral vector containing a polynucleotide sequence contains two different affinity tag sequences, one of the two affinity tag sequences encodes streptavidin-binding peptide and other encodes calmodulin binding peptide |
| 07/21/2005 | US20050158710 Oligonucleotide primers and/or hybridization probes for use as diagnostic tools in detecting picornavirus infection; diagnosing gastrointestinal disorders |
| 07/21/2005 | US20050158709 Determining effect of human serum protein on viricidal agents; bioassay; enzyme inhibitors; plasma protein binding and drug efficacy; drug screening and pharmacokinetics |
| 07/21/2005 | US20050158708 High thoughput assay; rapid profiling; proteomics |
| 07/21/2005 | US20050158707 Full - length genomic RNA of papaya leaf - distortion mosaic virus |
| 07/21/2005 | US20050158705 Gene screening method using nuclear receptor |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself |
| 07/21/2005 | US20050158372 Immunoliposome-nucleic acid amplification (ILNAA) assay |
| 07/21/2005 | US20050158344 Exoenzyme toxin of aeromonas salmonicida, and uses thereof |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158324 Using anti-Beta Casein Like Protein antibodies specific for cancer cells as antiproliferative agents; measuring and comparing BCLP mRNA expression to normal tissue to diagnose colon, breast, lung, ovary, prostate, pancreas or skin cancers; tissue-targeted therapy |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158298 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; |
| 07/21/2005 | US20050158292 Lactococcus induces production of IL-10 from mammalian dendritic or spleen cells; treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer) |
| 07/21/2005 | US20050158280 Method of reducing angiogenesis |
| 07/21/2005 | US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers |
| 07/21/2005 | US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 07/21/2005 | US20050157915 Method and apparatus for providing a bioinformatics database |
| 07/21/2005 | US20050157300 Biochip scanner device |
| 07/21/2005 | US20050155415 Process and device for determining viscosity |
| 07/21/2005 | DE10359160A1 Testelement zur Untersuchung von Probenmaterial Test element for the analysis of sample material |
| 07/21/2005 | DE10358332A1 Verfahren, Computerprogramm mit Progammcode-Mitteln und Computerprogramm-Produkt zur Analyse eines regulatorischen genetischen Netzwerks einer Zelle Method, computer program comprising program code means and computer program product for analyzing a genetic regulatory network of a cell |
| 07/21/2005 | DE10321480B4 Verfahren zur Identifizierung von Zellinien A process for the identification of cell lines |
| 07/21/2005 | DE10201463B4 Reaktionsgefäß zur Durchführung von Array-Verfahren Reaction vessel for carrying out array method |
| 07/21/2005 | DE102004059710A1 Preparing a biological sample containing DNA for automatic isolation comprising concentrating and stabilizing in a lysis bonding buffer system without using large samples or centrifuges |
| 07/21/2005 | DE102004045139A1 Dendrimer-basierte DNA-Extraktionsverfahren und Biochips Dendrimer-based DNA extraction procedure and biochips |
| 07/21/2005 | DE102004045133A1 Biochip-Substrathalteverfahren und Biochip-Leser Biochip substrate holding method and biochip reader |
| 07/21/2005 | DE10116586B4 Testsystem zur Bestimmung der Hämostaseaktivierung von biologischen Flüssigkeiten Test system for determining the hemostasis of biological fluids |
| 07/21/2005 | DE10109012B4 Detektionsverfahren für kariogene Keime Detection method for cariogenic bacteria |
| 07/21/2005 | CA2638973A1 Biosensor and method of making |
| 07/21/2005 | CA2552815A1 Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies |
| 07/21/2005 | CA2552113A1 Staphylococcus detection |
| 07/21/2005 | CA2552010A1 Method for enriching and stabilising components which contain dna and which are made of biological materials |
| 07/21/2005 | CA2552007A1 Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids |
| 07/21/2005 | CA2551886A1 Use of cathepsin z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases |
| 07/21/2005 | CA2550854A1 Membranes incorporating recognition moieties |
| 07/21/2005 | CA2550820A1 Use of fluorinated nonionic surfactants for reducing nonspecific binding of molecules to a surface |
| 07/21/2005 | CA2550642A1 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | CA2550245A1 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
| 07/21/2005 | CA2549532A1 Bioluminescent assays and cells useful therein |
| 07/20/2005 | EP1555530A1 Method for quantitatively determining homocysteine and a reagent for quantitative determination of homocysteine |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555327A1 Method and reagent for measuring cholesterol in high-density lipoproteins |
| 07/20/2005 | EP1555326A1 Method and reagent for measuring cholesterol in high density lipoproteins |
| 07/20/2005 | EP1555325A1 Novel fructosyl peptide oxidase and utilization thereof |
| 07/20/2005 | EP1555324A1 Defructosylation method |
| 07/20/2005 | EP1555314A2 Enzymes and detergent compositions |
| 07/20/2005 | EP1555313A2 Method for the identification of hydroxyphenylpyruvate dioxygenase inhibitors |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1554931A1 Means for in vitro activating cell nuclei |
| 07/20/2005 | EP1554587A2 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 07/20/2005 | EP1554586A2 Screening method |
| 07/20/2005 | EP1554583A1 The use of the a3 adenosine receptor as a marker for a disease state |
| 07/20/2005 | EP1554579A2 Methods of secretory vimentin detection and modulation |
| 07/20/2005 | EP1554578A2 Identification of inhibitors of mitosis |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554567A2 Analyte sensors and methods for making them |
| 07/20/2005 | EP1554408A2 Method for diagnosing diffuse-type gastric cancers |
| 07/20/2005 | EP1554407A2 Method and nucleic acids for the treatment of breast cell proliferative disorders |
| 07/20/2005 | EP1554404A1 Detection system |
| 07/20/2005 | EP1554403A1 Autism gene |
| 07/20/2005 | EP1554402A2 Real-time detection of nucleic acid reactions |
| 07/20/2005 | EP1554401A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 07/20/2005 | EP1554400A1 Methods to predict edema as a side effect of drug treatment |
| 07/20/2005 | EP1554399A1 Detecting the risk of cardiovascular diseases by detecting mutations in genes, including genes encoding a2b-adrenoceptor and apolipoprotein b |
| 07/20/2005 | EP1554398A2 Apparatus and method for preparative scale purification of nucleic acids |
| 07/20/2005 | EP1554397A2 Type 2 diabetes susceptibility genes |
| 07/20/2005 | EP1554396A2 Displacement assay for the detection of nucleic acid oligomer hybridization events |
| 07/20/2005 | EP1554394A2 Asparaginyl hydroxylases and modulators thereof |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554377A2 Thermostable reverse transcriptases and uses thereof |
| 07/20/2005 | EP1554376A2 Soluble rna polymerase protein and methods for the use thereof |
| 07/20/2005 | EP1553983A2 New settings for recombinant adenoviral-based vaccines |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553831A2 Process for screening fungitoxic compounds |
| 07/20/2005 | EP1527194A4 Nucleic acid reactions using labels with different redox potentials |
| 07/20/2005 | EP1513950A4 Application of cantilevers in nucleic acid sequencing |
| 07/20/2005 | EP1463808A4 High fidelity dna polymerase compositions and uses therefor |
| 07/20/2005 | EP1444365A4 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons |
| 07/20/2005 | EP1427821A4 Biosensor for small molecule analytes |
| 07/20/2005 | EP1425416A4 A high throughput method for identification of sequence tags |
| 07/20/2005 | EP1423091A4 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids |
| 07/20/2005 | EP1421095A4 Assay for detection of human parvovirus b19 nucleic acid |
| 07/20/2005 | EP1386001A4 Kits and methods for assessing oxidative stress |
| 07/20/2005 | EP1324736A4 Rapid antibiotic susceptibility test |